Clinical Trials Directory

Trials / Completed

CompletedNCT01379040

Volatile Organic Compounds in Cystic Fibrosis

Detection of Pulmonary Colonization in Cystic Fibrosis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
Landon Pediatric Foundation · Academic / Other
Sex
All
Age
1 Year – 40 Years
Healthy volunteers
Accepted

Summary

This experiment is designed to test the effectiveness of a new electronic nose device, which allows a non-invasive breath test for markers of lower respiratory tract infection, which may predict the probability of bacterial organisms in the lower respiratory tract. It consists of: * A breath collection apparatus for collection of volatile organic compounds in breath onto a sorbent trap and Tedlar bag, as well as for the collection of a separate sample of room air. * Analysis of the volatile organic compounds in breath and room air by short acoustic wave/gas chromatography. * Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of lower respiratory tract colonization and infection. This study will test the hypothesis that the investigators can identify the presence of Pseudomonas aeruginosa by sampling the "head space" above culture media of sputum provided by patients with cystic fibrosis. This study will test the additional hypothesis that the investigators can identify the presence of Pseudomonas aeruginosa by sampling exhaled breath from the patient providing the sputum.

Conditions

Interventions

TypeNameDescription
OTHERCystic Fibrosis patients

Timeline

Start date
2009-08-01
Primary completion
2009-12-01
Completion
2010-12-01
First posted
2011-06-23
Last updated
2014-08-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01379040. Inclusion in this directory is not an endorsement.